Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNMC.L Regulatory News (NMC)

  • There is currently no data for NMC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement regarding NMC Health plc

9 Mar 2020 16:18

RNS Number : 4900F
GKSD Investment Holding SA
09 March 2020
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO OR FROM, ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE").

 

FOR IMMEDIATE RELEASE

 

Statement from GKSD Investment Holding SA ("GKSD"),

a company backed by sponsors of Gruppo San Donato ("GSD")

 

No intention to offer for NMC Health plc ("NMC")

Further to the announcements by GKSD dated 11 February 2020 and NMC dated 10 February 2020, GKSD announces that it does not intend to make a firm offer for NMC.

 

Gruppo San Donato is one of the largest hospital groups in Europe with approx. 17,000 employees offering clinical excellence to approx. 5 million patients per year. GSD is also the principal centre for medical research in Italy. GSD will maintain its offer of operational support to NMC to assist the NMC business in its continued delivery of a high standard of healthcare in the EMEA region.

 

As a result of this announcement, GKSD and any person(s) acting in concert with it will be bound by the restrictions contained in Rule 2.8 of the Code.

 

For the purposes of Rule 2.8 of the Code, GKSD, and any person(s) acting in concert with it reserves the right to make or participate in an offer or possible offer for NMC (and/or take any other action which would otherwise be restricted under Rule 2.8 of the Code) within 6 months following the date of this announcement:

 

(i) with the agreement of the Board of NMC;

(ii) following the announcement of a firm intention to make an offer for NMC by a third party;

(iii) following the announcement by NMC of a "whitewash" proposal (for the purposes of Note 1 on the Notes on Dispensations from Rule 9 of the Code) or a reverse takeover; or

(iv) if the Panel on Takeovers and Mergers determines that there has been a material change of circumstances.

Enquiries

Rothschild & Co +44 207 280 5000

Hedley Goldberg

Thibault Poirier

 

Goldman Sachs International +44 20 7774 1000

Ben Thorpe

Chris Emmerson

 

Morgan Stanley +44 20 7425 8000

Matthew Jarman

Duncan Williamson

 

Important Notices

N.M. Rothschild & Sons Limited ("Rothschild & Co"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting as financial adviser for GKSD and for no one else in connection with the subject matter of this announcement and will not be responsible to anyone other than GKSD for providing the protections afforded to its clients or for providing advice in connection with the subject matter of this announcement.

Goldman Sachs International, which is authorised by the Prudential Regulation Authority ("PRA") and regulated by the PRA and the Financial Conduct Authority ("FCA") in the United Kingdom, is acting exclusively for GKSD and for no one else in connection with the possible offer and will not be responsible to anyone other than GKSD for providing the protections afforded to its clients or for providing advice in relation to the possible offer, the contents of this announcement or any other matters referred to in this announcement.

Morgan Stanley & Co. International plc ("Morgan Stanley") which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the UK is acting as financial adviser exclusively for GKSD and no one else in connection with the matters set out in this announcement. In connection with such matters, Morgan Stanley, its affiliates and their respective directors, officers, employees and agents will not regard any other person as their client, nor will they be responsible to any other person for providing the protections afforded to their clients or for providing advice in connection with the contents of this announcement or any other matter referred to herein.

 

MAR

The information contained within this announcement is considered by GKSD to constitute inside information as stipulated under the Market Abuse Regulations (EU) No.596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information will be considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OFDFLFLRVVIAIII
Date   Source Headline
19th Mar 20184:01 pmRNSSale of Shares
19th Mar 20183:55 pmRNSExercise of share options
15th Mar 20184:56 pmRNSAmendment: Exercise of Options and Sale of Shares
15th Mar 20184:24 pmRNSGrant of Options
9th Mar 201811:02 amRNSGrant of Options
9th Mar 201811:02 amRNSGrant of Options
7th Mar 20187:00 amRNSFinal Results
28th Feb 201812:36 pmRNSNotice of Results
8th Feb 20189:08 amRNSDirector/PDMR Shareholding
6th Feb 20183:13 pmRNSDirector/PDMR Shareholding
2nd Feb 20187:00 amRNSAppointment of Joint Corporate Broker
29th Jan 20187:00 amRNSCompletion of Fakih IVF acquisition
22nd Jan 20187:00 amRNSEarnings accretive acquisitions in the UAE and KSA
4th Jan 20187:00 amRNSAcquisitions of outstanding minority interests
20th Dec 20177:00 amRNSGroup Strategy & Trading Update
11th Dec 20171:42 pmRNSDirector/PDMR Shareholding
1st Dec 20171:46 pmRNSDirector/PDMR Shareholding
30th Nov 20171:39 pmRNSTotal Voting Rights
28th Nov 20174:25 pmRNSDirector/PDMR Shareholding
24th Nov 20171:26 pmRNSPDMR Notification
17th Nov 20172:09 pmRNSDirector/PDMR Shareholding
17th Nov 20172:00 pmRNSExercise of share options
26th Oct 20171:28 pmRNSShare Plans Block Listing Application
13th Oct 20179:46 amRNSPDMR notification
25th Sep 20178:00 amRNSSignificant Expansion into Kingdom of Saudi Arabia
22nd Sep 20171:47 pmRNSDirector/PDMR Shareholding
19th Sep 20171:24 pmRNSHolding(s) in Company
14th Sep 20179:11 amRNSHolding(s) in Company
8th Sep 20174:22 pmRNSDirector/PDMR Shareholding
7th Sep 20173:40 pmRNSDirector/PDMR Shareholding
23rd Aug 20177:15 amRNSNew O&M Contract
23rd Aug 20177:00 amRNSHalf-year Report
22nd Aug 20172:37 pmRNSHolding(s) in Company
18th Aug 20177:00 amRNSNotice of Results
20th Jul 20172:40 pmRNSPDMR Notification
11th Jul 20172:18 pmRNSHolding(s) in Company
29th Jun 20177:02 amRNSNMC Health Board Changes
29th Jun 20177:00 amRNSTransfer of shareholding between concert parties
12th Jun 201711:00 amRNSDirector/PDMR Shareholding
9th Jun 20172:30 pmRNSDirector/PDMR Shareholding
23rd May 20174:08 pmRNSResults of Voting at AGM
18th May 20174:43 pmRNSDirector/PDMR Shareholding
9th May 20174:39 pmRNSDirector/PDMR Shareholding
2nd May 20177:00 amRNSAbu Dhabi regulatory and trading update
24th Apr 20173:38 pmRNSNMC Health AGM and Dividend Timetable
24th Mar 201710:25 amRNSNMC Completion of Acquisition of Al Zahra Hospital
8th Mar 20178:00 amRNSNMC Health promotes Prasanth Manghat to CEO
8th Mar 20177:00 amRNSNMC Final FY 2016 Results
2nd Mar 201711:56 amRNSUPDATE ON PROPOSED ACQUISITION OF AL ZAHRA
1st Mar 20177:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.